COVID-19. COVID-19, virus not identified
Conditions
Interventions
Intervention 1: Intervention group: In addition to the conventional treatments for Covid-19, patients will undergo a cycle of Ozone Major Autohemotherapy. In this method, a specific volume of patient
Sponsors
Bagheiat-allah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who have been diagnosed with COVID-19
Exclusion criteria
Exclusion criteria: Patients with hypersensitivity to ozone Patients with abnormal thyroid function tests Patients with abnormal coagulation tests Patients with G6PD deficiency Pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative CRP. Timepoint: Before and after the intervention. Method of measurement: Lab kit.;Oxygen Saturation. Timepoint: Before and after the intervention. Method of measurement: Pulse Oximetry.;Body's temperature. Timepoint: Before and after the intervention. Method of measurement: Thermometer.;Dyspnea. Timepoint: Before and after the intervention. Method of measurement: Subjective assessment of the patient and physical examination.;Cough. Timepoint: Before and after the intervention. Method of measurement: subjective assessment of the patient.;Diarrhea. Timepoint: before and after the intervention. Method of measurement: subjective assessment of the patient.;Headache. Timepoint: Before and after the intervention. Method of measurement: Subjective assessment of the patient.;Chills. Timepoint: Before and after the intervention. Method of measurement: Subjective assessment of the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Sarrafzadeh
Bagheiat-allah University of Medical Sciences
Outcome results
None listed